Halozyme Therapeutics shares owned by First Trust Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by First Trust Advisors
from 13F filings
Historical chart of First Trust Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by First Trust Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by First Trust Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $57M | 776k | 73.34 |
| 2025-06-30 | $40M | 766k | 52.02 |
| 2025-03-31 | $51M | 804k | 63.81 |
| 2024-12-31 | $41M | 860k | 47.81 |
| 2024-09-30 | $50M | 877k | 57.24 |
| 2024-03-31 | $49M | 1.2M | 40.68 |
| 2023-09-30 | $289k | 7.6k | 38.20 |
| 2023-06-30 | $202k | 5.6k | 36.07 |
| 2023-03-31 | $4.0M | 105k | 38.19 |
| 2022-12-31 | $3.1M | 54k | 56.90 |
| 2022-09-30 | $4.4M | 111k | 39.54 |
| 2022-06-30 | $3.5M | 81k | 44.00 |
| 2022-03-31 | $2.1M | 52k | 39.87 |
| 2021-12-31 | $2.3M | 57k | 40.21 |
| 2021-09-30 | $5.0M | 122k | 40.68 |
| 2021-06-30 | $3.8M | 84k | 45.41 |
| 2021-03-31 | $5.8M | 139k | 41.69 |
| 2020-12-31 | $3.5M | 83k | 42.71 |
| 2020-09-30 | $1.6M | 60k | 26.27 |
| 2020-06-30 | $2.7M | 100k | 26.81 |
| 2020-03-31 | $245k | 14k | 17.98 |
| 2019-09-30 | $669k | 43k | 15.51 |
| 2019-03-31 | $1.6M | 98k | 16.10 |
| 2018-12-31 | $1.2M | 82k | 14.63 |
| 2018-09-30 | $655k | 36k | 18.18 |
| 2018-06-30 | $2.7M | 159k | 16.87 |
| 2018-03-31 | $1.7M | 85k | 19.59 |
| 2017-12-31 | $1.6M | 78k | 20.26 |
| 2017-09-30 | $652k | 38k | 17.37 |
| 2017-06-30 | $912k | 71k | 12.83 |
| 2017-03-31 | $203k | 16k | 12.96 |
| 2016-12-31 | $1.1M | 108k | 9.88 |